Trademark: 90022437
Word
IMGT IMAGE GUIDED THERAPY
Status
Pending
Status Code
686
Status Date
Tuesday, August 17, 2021
Serial Number
90022437
Mark Type
3000
Filing Date
Friday, June 26, 2020
Published for Opposition
Tuesday, August 17, 2021

Trademark Owner History
IMGT Co., Ltd. - Owner At Publication

Classifications
5 Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Enzymes for medical purposes; Pharmaceutical preparations acting on the central nervous system; Antibiotic preparations; Chemotherapeutics; Veterinary vaccines; Vaccines; Chemical reagents for medical or veterinary purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of CNS disorders; Pharmaceutical preparations for the treatment of peripheral vascular or neurologic disease; Pharmaceutical preparations for the treatment of lesions; Pharmaceutical preparations for reliving pain; Pharmaceutical preparations for activating drug delivery; Nutraceuticals for use as a dietary supplement for promoting digestion; Anti-cancer preparations
10 Medical apparatus, namely, medical ultrasound apparatus; Medical apparatus, namely, ultrasound diagnostic apparatus; Medical instruments for use in general surgery; Medical apparatus for treating cancer; Medical apparatus for treating cancer by using ultrasound; Medical apparatus for treating CNS disorders; Medical apparatus for treating CNS disorders by using ultrasound; Medical apparatus for treating peripheral vascular or neurologic disease; Medical apparatus for treating peripheral vascular or neurologic disease by using ultrasound; Medical apparatus for treating dermatological disease by using ultrasound; Medical apparatus for treating dermatological disease; Medical apparatus for treatment of lesions; Medical apparatus for treatment of lesions through hyperthermia caused by using ultrasound; Medical apparatus for relieving pain; Medical apparatus for relieving pain by using ultrasound; Medical apparatus for activating drug delivery; Medical apparatus for activating drug delivery by using ultrasound; Syringes for medical purposes and for injections; Medical apparatus for detecting cancer; Dental instruments, namely, picks, burrs, mirrors, prophy angles, oral irrigators, crown and bridge removers; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Diagnostic apparatus for the detection of periodontal disease; Diagnostic apparatus for the detection of cancer; Medical diagnostic apparatus for detecting cancer; Injection device for pharmaceuticals; Syringes for medical purposes; Syringes for injection of medical substances; Hypodermic syringes
42 Drug discovery services; Biotechnology research; Biomedical research services; Laboratory research in the field of biology; Providing information on the subject of scientific research in the field of Biochemistry and biotechnology; Biological research; Bacteriological research; Pharmaceutical research and development; Research on the subject of pharmaceuticals; Clinical research in the field of medicines for detection and treatment of cancer; Conducting clinical trials for others in the field of medicines for detection and treatment of cancer; Medical research services; Scientific research for medical purposes in the field of cancer; Testing of pharmaceuticals; Testing of materials; Chemical research and analysis; Chemical research services
The color(s) blue and light blue is/are claimed as a feature of the mark.
"IMAGE GUIDED THERAPY"
The mark consists of a bent molecule feature composed of a larger light blue orb with blue shading connected with two smaller light blue orbs with blue shading, next to the stylized wording of "IMGT" in blue, over the stylized wording of "IMage Guided Therapy" where the letters, "IM" are in blue, "age" are in light blue, "G" are in blue, "uided" are in light blue, "T" are in blue, and "herapy" are in light blue.

Trademark Events
Aug 17, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 17, 2021
Published For Opposition
Jul 28, 2021
Notification Of Notice Of Publication E-Mailed
Jul 12, 2021
Approved For Pub - Principal Register
Jun 15, 2021
Teas/Email Correspondence Entered
Jun 15, 2021
Correspondence Received In Law Office
Jun 7, 2021
Teas Response To Suspension Inquiry Received
Mar 22, 2021
Notification Of Letter Of Suspension E-Mailed
Mar 22, 2021
Letter Of Suspension E-Mailed
Mar 22, 2021
Suspension Letter Written
Mar 19, 2021
Teas/Email Correspondence Entered
Mar 19, 2021
Correspondence Received In Law Office
Mar 19, 2021
Teas Response To Office Action Received
Oct 2, 2020
Combined Examiner's Amendment/Priority Action Entered
Oct 2, 2020
Assigned To Lie
Oct 2, 2020
Notification Of Examiner's Amendment/Priority Action E-Mailed
Oct 2, 2020
Examiner's Amendment/Priority Action E-Mailed
Oct 2, 2020
Examiners Amendment And/Or Priority Action - Completed
Sep 29, 2020
Assigned To Examiner
Jul 24, 2020
Notice Of Design Search Code E-Mailed
Jul 23, 2020
New Application Office Supplied Data Entered In Tram
Jun 30, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24